EDGAR Filing Documents for 0001213900-23-082459

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-23-082459

Filing Date

2023-11-02

Accepted

2023-11-02 09:05:39

Documents

Period of Report

2023-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	f10q0923_actiniumphar.htm iXBRL	10-Q	846520
2	AMENDMENT TO EMPLOYMENT AGREEMENT, DATED NOVEMBER 1, 2023, BY AND BETWEEN ACTINI	f10q0923ex10-1_actiniumphar.htm	EX-10.1	11250
3	CERTIFICATION	f10q0923ex31-1_actiniumphar.htm	EX-31.1	8900
4	CERTIFICATION	f10q0923ex31-2_actiniumphar.htm	EX-31.2	8921
5	CERTIFICATION	f10q0923ex32-1_actiniumphar.htm	EX-32.1	3808
6	CERTIFICATION	f10q0923ex32-2_actiniumphar.htm	EX-32.2	4291
7	GRAPHIC	image_001.jpg	GRAPHIC	29794
8	GRAPHIC	image_002.jpg	GRAPHIC	27102
9	GRAPHIC	image_003.jpg	GRAPHIC	31960
10	GRAPHIC	image_004.jpg	GRAPHIC	26698
11	GRAPHIC	image_005.jpg	GRAPHIC	18595
12	GRAPHIC	image_006.jpg	GRAPHIC	25986
13	GRAPHIC	image_007.jpg	GRAPHIC	24824
14	GRAPHIC	image_008.jpg	GRAPHIC	16766
15	GRAPHIC	image_009.jpg	GRAPHIC	25290
16	GRAPHIC	image_010.jpg	GRAPHIC	15178
17	GRAPHIC	image_011.jpg	GRAPHIC	21538
18	GRAPHIC	image_012.jpg	GRAPHIC	28344
19	GRAPHIC	image_013.jpg	GRAPHIC	36804
	Complete submission text file	0001213900-23-082459.txt		4399862

Data Files

Seq	Description	Document	Type	Size
20	XBRL SCHEMA FILE	atnm-20230930.xsd	EX-101.SCH	31150
21	XBRL CALCULATION FILE	atnm-20230930_cal.xml	EX-101.CAL	29385
22	XBRL DEFINITION FILE	atnm-20230930_def.xml	EX-101.DEF	157631
23	XBRL LABEL FILE	atnm-20230930_lab.xml	EX-101.LAB	327719
24	XBRL PRESENTATION FILE	atnm-20230930_pre.xml	EX-101.PRE	174118
55	EXTRACTED XBRL INSTANCE DOCUMENT	f10q0923_actiniumphar_htm.xml	XML	287901

Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017

Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870

Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)